Let’s see how CBD could be used for Parkinson’s disease.
CBDistillery’s mission is to provide high-quality CBD oils affordable for everyone. The company sells hemp extracts in full-spectrum and broad-spectrum variants. The latter is referred to as “pure oil” and contains all the non-psychoactive cannabinoids and terpenes from hemp, but without any THC in the final product.
CBD can be a healthy, natural alternative to traditional treatments for Parkinson’s Disease.
CBD appears to help with those nonmotor symptoms and potential side effects, rather than physical problems. A study with more than 200 participants found that regular use of cannabis was highly effective on non-motor symptoms of Parkinson’s Disease. However, this study included a combination of THC with CBD, not CBD oil alone.
While antipsychotic medications are available to treat this symptom, some people have wondered if CBD might help too.
CBD is a compound found in the cannabis plant. Unlike another component, THC, CBD is non-addictive and doesn’t cause intoxication. You may have already heard of it because of its potential as a treatment for epilepsy and multiple sclerosis.
This project is the first clinical trial to go through the Virtual Biotech and the 6th project overall.
In a world first clinical trial, researchers will test whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms with the help of the Virtual Biotech.
Our Virtual Biotech operates in the same way but instead of doing it for profit, like a standard biotech, we’re doing it for people affected by Parkinson’s. We don’t own our own labs, hi-tech specialist equipment or employ a team of scientists because this would be enormously expensive. Instead, we’re taking an efficient approach. Partnering with institutions and pharmaceutical companies worldwide that already have the expertise, tools and infrastructure. In a chronically underfunded area, this means more money can be put into promising treatments.
Hallucinations and delusions are common symptoms of Parkinson’s. Around 60% of people experience these distressing symptoms. Current treatments can make other Parkinson’s symptoms worse, as they block dopamine receptors in the brain. This makes this research even more exciting as the existing information we have on CBD suggests it has no side effects.
While some results have been positive, the effects of medical marijuana are probably not completely understood, which is why more studies, especially those with more subjects, are needed. Most doctors don’t support study results because these studies do not meet minimum research standards.
Thirty-five states and Washington, DC have passed legislation allowing the use of marijuana-based products.
PD-Related Medicinal Marijuana Trials
PD is listed as a qualifying condition for medical marijuana in Connecticut, Florida, Illinois, Louisiana, Massachusetts, Michigan, Mississippi, Missouri, New Hampshire, New Mexico, New York, Ohio, Pennsylvania and West Virginia.
The results were interesting: most experts said they knew what cannabis did, but disagreed on the details. While there is no general agreement on what the benefits might be for people with PD, the survey confirmed that cannabis is a popular subject within Parkinson’s Foundation centers as 95 percent of neurologists reported patients have asked them to prescribe it.
Medical marijuana is legal in Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Utah, Vermont, Washington, West Virginia and Washington, DC.